Total Count 71

AVALON PHARMA - Latest News

16/04/2026
Avalon Pharma names Ahmad Al Tabbaa as Chairman
Argaam
12/04/2026
Avalon Pharma shareholders OK 2026 interim dividends mandate
Argaam
05/04/2026
Avalon Pharma obtains CMA nod for capital hike via bonus shares
Argaam
08/03/2026
Avalon Pharma to distribute 13.2% cash dividend for H2 2025
Argaam
04/02/2026
Avalon Pharma signs agreement with Chinese company to register, market drug in Middle East
Argaam
01/02/2026
Avalon Pharma board recommends 75% capital hike via bonus issue
Argaam
01/01/2026
SNB Capital: TASI likely to trade between 10,000-11,700 pts in 2026
ِArgaam
26/11/2025
Avalon Pharma signs MoU with Benta SAS to localize innovative products in Saudi Arabia
Argaam
09/11/2025
Avalon Pharma’s CEO says Q3 profit margins hit by seasonal factors
Argaam
02/11/2025
Avalon Pharma inks MoU with NUPCO for supply continuity
Argaam
10/09/2025
Avalon Pharma renews bank facilities worth SAR 78M
Argaam
25/08/2025
Avalon Pharma renews SAR 54.2M credit facilities deal with SAIB
Argaam
13/08/2025
Avalon Pharma to distribute 11% cash dividend for H1 2025
Argaam
05/08/2025
Avalon Pharma signs EUR 3M contract to market weight loss and obesity products
Argaam
07/07/2025
GIB Capital issues Q2 2025 earnings forecasts for Saudi companies
Argaam
06/07/2025
Q2 2025 earnings preview: AlJazira Capital
Argaam Special
03/07/2025
Al Rajhi Capital issues earnings estimates for Q2 2025
Argaam
01/06/2025
Avalon Pharma to transfer SAR 25.3M reserve to retained earnings
Argaam
18/05/2025
Avalon Pharma renews SAR 50M credit agreement with Alinma Bank
Argaam
07/05/2025
Q1 2025 earnings: What to expect for Avalon Pharma
Argaam Special
29/04/2025
AlJazira Capital initiates coverage on Saudi pharmaceuticals sector, sets ratings
Argaam
17/04/2025
Avalon Pharma recommends transfer of SAR 25.3M statutory reserves to retained earnings
Argaam
14/04/2025
Al Rajhi Capital issues Q1 2025 profit forecasts for TASI-listed firms
Argaam
14/04/2025
GIB Capital issues Q1 2025 earnings estimates
Argaam
13/04/2025
Avalon Pharma to distribute 12.5% cash dividend for H2 2024
Argaam
10/04/2025
SNB Capital sets Q1 2025 earnings estimates
Argaam
26/02/2025
Avalon Pharma secures SAR 30M loan from SIDF
Argaam
24/02/2025
FTSE Russell announces semi-annual review of Saudi companies
Argaam
18/02/2025
What you need to know ahead of Avalon Pharma Q4 2024 earnings report
Argaam Special
12/01/2025
SNB Capital sets Q4 2024 earnings estimates
Argaam Special
12/01/2025
Osool & Bakheet previews Q4 2024 earnings estimates
Argaam Special
06/01/2025
GIB Capital issues Q4 2024 earnings estimates
Argaam
02/01/2025
Al Rajhi Capital issues Q4 2024 profit forecasts for TASI-listed firms
Argaam Special
12/12/2024
Avalon Pharma plans to invest over SAR 100M in new plants, regional expansion: CEO
Argaam
11/11/2024
SNB Capital says Avalon Pharma’s Q3 2024 profit below estimates
Argaam
04/11/2024
Avalon Pharma secures SAR 30M facilities from SAB
Argaam
10/10/2024
GIB Capital's forecast on Q3 2024 earnings
Argaam Special
08/10/2024
Osool & Bakheet previews Q3 2024 earnings estimates
Argaam Special
07/10/2024
Al Rajhi Capital issues Q3 2024 earnings forecasts for more Tadawul-listed firms
Argaam
06/10/2024
SNB Capital sets Q3 2024 earnings estimates
Argaam
09/09/2024
Saudi pharmaceuticals sector seen to grow: Al Rajhi Capital
ِArgaam
26/08/2024
Trading ban on Avalon Pharma’s major shareholders ends today
Argaam Special
01/08/2024
Avalon Pharma obtains SAR 55M credit facilities from Alinma Bank
Argaam
30/07/2024
Avalon Pharma board nods to 7.5% cash dividend for H1 2024
Argaam
09/07/2024
Osool & Bakheet issues Q2 2024 earnings forecast
Argaam
09/07/2024
Avalon Pharma obtains SAR 70M credit facilities from Emirates NBD
Argaam
07/07/2024
GIB Capital previews Q2 2024 earnings
Argaam
07/07/2024
SNB Capital issues Q2 2024 earnings estimates
Argaam
04/07/2024
Al Rajhi Capital issues Q2 2024 profit forecasts
Argaam
01/07/2024
Avalon Pharma EGM authorizes board to pay interim dividends for 2024
Argaam

Popular Links

Quick Links

Join Us

Argaam.com Copyright © 2026, Argaam Investment, All Rights Reserved
Call Request